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Executive summary

1. Executive summary
This report documents a service evaluation of
Population Services Zimbabwe (PSZ) mobile outreach
programme in four provinces of Zimbabwe. The
evaluation was conducted by the Population Council
between September and October 2013. This study was
made possible through the United States Agency for
International Development (USAID) funded Support for
International Family Planning Organizations - Marie
Stopes International (SIFPO-MSI) project. It provides
key findings on the quality of the PSZ outreach
programme in expanding choice and access to
long-acting reversible contraceptives (LARCs) and
permanent methods (PMs) of contraception, as well as
recommendations for PSZ and other family planning
programmes to consider in scaling up and
strengthening mobile outreach services. The
evaluation, conducted by Population Council, was
designed to focus on various components of quality
including adequate information and counselling on
methods and services, good clinical procedure with
minimal occurrence of adverse events, client healthseeking behaviour and client satisfaction. The level of
integration of HIV and other SRH-related services into
the family planning programme was also evaluated.
The fertility rate in Zimbabwe is 4.1 children per woman
and the contraceptive prevalence rate (CPR) is 59%
[1]. The most recent Zimbabwe Demographic and
Health Survey (ZDHS) 2010-2011 reported that if all
married women with an unmet need for family planning
were to use contraception, the CPR would increase
from 59% to 74% [1]. Government-sponsored facilities
in Zimbabwe remain the main providers of
contraceptive methods, where 73% of all women who
use modern contraceptive methods obtain them from
the public sector. Integration of other services into
sexual and reproductive health services, including HIV,
has been outlined in the National Strategic Plan and
other health policies through support of the Ministry of
Health and Child Care (MOHCC). As a result, family
planning services and clinics are now to provide HIV
testing and counselling and other reproductive health
services according to the 2011-2015 ZNASP [2].
Marie Stopes International (MSI) uses a mobile
outreach model to increase the availability and choice
of family planning services, with a particular focus on
expanding access to LARCs/PMs among men and
women living in rural and hard to reach areas. PSZ, a
member of MSI Global Partnership, is one of

Zimbabwe’s largest specialised SRH organisations,
known for providing a wide range of high quality,
affordable and client-oriented services. PSZ currently
provides mobile outreach services through eight teams
covering over 500 sites throughout the country. The
mobile teams (consisting of four to five staff)
complement the government’s facility level services
with a focus on areas where family planning is not
otherwise available. The service includes providing
short-term family planning services (pills, condoms,
emergency contraception, and injectables), LARCs
(implants, IUDs) and PMs (tubal ligation and
vasectomy).
While expanding the availability of family planning
methods is important, it is equally important that the
quality of these services are maintained to ensure that
family planning procedures are safe and meet the
expectations of clients. Under the auspices of the
USAID-funded SIFPO-MSI project, Population Council
carried out an evaluation of PSZ’s mobile outreach
services in four provinces in order to inform and
improve PSZ’s family planning service provision.
Between September and October 2013, 665 women
receiving a tubal ligation, implant or IUD were recruited
from high volume sites for the study. Data collection
included observing client-provider interaction and
service provision as well as interviewing clients
immediately following the service on the day of the
procedure. Clients were then asked to return 15 days
post procedure, at which point they were interviewed
about adverse events and health seeking behaviour.
The median age of clients was 26 years and 43% had
a child less than a year old. All except one client (664)
reported having living children of which 22% (n=145)
reported having one living child and 31% (n=207) had
two living children. 23% (n=153) reported having three
living children and 11% (n=74) reported having four
living children. 40% of clients reported that they
planned to have a child “more than five years from
now”. Most women in the study had achieved primary
or secondary education, with clients from rural areas
achieving a lower educational status (primary)
compared to those from urban areas. 39% (n=260) of
clients reported having discussed seeking family
planning services with their partner/spouse.
Information on HIV testing and sexual risk behaviour
was collected during the client exit interview. 95% of
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clients reported that they had been tested for HIV at
some point in the past. 19% of clients reported having
more than one partner in the past 12 months. Condom
use was low as only half of the women (49%, n=272)
reported “ever” having used a condom (male or
female) of which only 29% (n=79) reported “always”
using a condom and 24% reported that they had
unprotected sex in the last three months. This
indicates that clients may be at significant risk of HIV
and would likely benefit from HIV-related information
and services.
Data from the client exit interviews showed that 91% of
clients chose an implant as their preferred method of
contraception, 7% chose an IUD and 1% chose tubal
ligation. Client satisfaction was high, with 100%
reporting that they would use the PSZ family planning
services again. However, only 68% reported that they
would refer the family planning service to a friend; 57%
reported that they would refer a family member; and
21% reported they would tell a stranger about the
service.
To assess quality of care including information provided
and level of integration of HIV/SRH services, research
nurses observed client-provider interactions.
Specifically, to measure integration of services, it was
observed whether clients received HIV and AIDS
counselling, counselling on dual protection, pregnancy
testing, gender-based violence and STI services
(information, testing & treatment). The presence of
obstetrics and breast cancer history screening was also
assessed. For all the clients (100%), it was observed
that they were provided with information on the risks
and benefits of the chosen method of contraception as
well as the risks and benefits of using male or female
condoms as a single or dual method of protection
against HIV. 61% of clients were provided with HIV and
AIDS counselling. 58% of clients were observed being
asked about STIs. 94% of clients were asked about
their obstetric history and 62% of clients were provided
information on gynecological issues including obstetrics
and breast cancer. In only 12% of observations gender
based violence (GBV) issues were discussed. In client
exit interviews, 95% of clients reported that they were
told by the providers on how to manage side effects
they may experience after receiving their choice of
family planning method.

1

As indicated from client exit interviews, a significant
proportion of clients had misconceptions regarding the
various contraceptive methods that persisted after the
group education and counselling. Some commonly
reported beliefs included: women who have never had
a baby cannot use an IUD or DMPA and IUDs cause
discomfort to the partner during sex. Some clients felt
that hormonal contraceptives could cause cancer and
as many as 29% of clients said pills can make a
woman sterile.
During the Day 15 follow-up visits, 91% of clients
(N=555) returned, all of whom were asked if they had
experienced a side effect1 and if so, whether they had
sought care when they had experienced the side
effect. 386 clients reported experiencing symptoms at
some point (i.e. on day of procedure up to and
including Day 15 follow up). Most clients reported
experiencing expected side effects on the day of the
procedure. 32% (n=180) of clients indicated that they
experienced a side effect up to Day 15. 96% of clients
did not experience a side effect requiring follow up
treatment.
Of the 4% (n=24) who did experience a side effect
requiring follow up one half called the PSZ helpline to
enquire about the side effect/s they had experienced.
Of those who called the helpline, half returned to the
facility and were seen by a facility provider prior to the
Day 15 follow up visit. One percent of all women (n=8)
experienced a constant temperature and fever and
had to visit the health facility to have the method
removed. These eight clients reported no longer
experiencing these side effects on the 15 day follow
up visit. Five of these eight clients reported being
satisfied with the follow up treatment they received
from the facility provider. One client, an IUD acceptor,
reported that the PSZ provider had observed a
moderate hematoma or bruising. This required wound
revision and the release of a build-up of blood and the
treatment and care was provided by the nurse from
the PSZ team at the Day 15 follow up.
The study demonstrated that the quality of service and
client satisfaction is high amongst all those that
received family planning services from PSZ mobile
outreach sites. Clients were able to articulate the
management of side effects during the client exit
interview on Day 1. The data reveals that there is

Side effects are defined as symptoms that are a result of the procedure or drug that is generally not a sign of a health problem, nor related to the skill
of the provider, and requires resting or no medical intervention or treatment. The client may be aware of the problem all the time but still able to do
normal daily activities
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some level of HIV and SRH integration into the PSZ
model of family planning, however not all clients are
being offered all services. Most clients that
experienced side effects were aware of how and
where to seek health services prior to their Day 15
follow up visit. Although a high number of adverse
events were reported, the majority were categorised
as either “very mild” or “mild” and constituted expected
side effects of the family planning method or
procedure. There were no serious complications
reported.

Recommendations for PSZ:
•		 Stronger integration of SRH services such as HIV
and STI counselling and testing could provide an
opportunity to intensify HIV prevention activities

amongst family planning clients such as HIV
re-testing and condom use.
•		 Only 39% (n=260) reported having discussed
family planning with their spouse or partner.
Therefore a recommendation may be to include
spouses or partners in family planning campaigns
to involve them in the family planning services
women receive with the aim to strengthen HIV and
SRH integration.
•		 A significant proportion of clients continue to have
misconceptions and incorrect information about the
various contraceptive methods. PSZ health care
providers should continue to focus on correcting
myths and misconceptions routinely in group or
individual counselling as part of their family
planning community outreach activities.
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Introduction

2. Introduction
Zimbabwe has a population of 13 million [1]. 41% of the
population is below the age of 15 years, 55% are
between 15 and 64 years and 4% are 65 years or older
[1]. The adolescent population is estimated to be
1,656,000 and the number of women of reproductive
age (15-49 years) is approximately 3,246,000 [3]. The
total fertility rate is 4.1 children per woman. For women
in Zimbabwe, childbearing during ages 20-24 years and
25-29 years is at its peak and then drops sharply after
the age of 39 years. Fertility among urban women is
markedly lower (3.1 children per woman) as compared
to rural women (4.8 children per woman). Zimbabwe’s
CPR is 59% and the proportion of women with an unmet
family planning need is 13% [1]. The Demographic
Health Surveys define unmet need for family planning
as “all fecund women who are married or living in union,
and thus presumed to be sexually active, who either do
not want any more children or who wish to postpone the
birth of their next child for at least two more years but
are not using any method of contraception” [1], [3].
Approximately 211,000 women want to delay or avoid
falling pregnant but do not have access to modern
methods of contraception [4]. Fertility has fallen among
women over the age of 20 years in the past two
decades, although there has been a noticeable increase
among those between 15 and 19 years [6]. Trends
reveal that fertility declined between 1988 and 2005/6,
from 5.4 children to 3.8 children per woman, but
increased in 2010/11 to 4.1 children per woman [1]. The
Zimbabwe Demographic and Health Survey (ZDHS)
2010-2011 reported that contraception use in Zimbabwe
has remained unchanged since 2005/6, and that if all
married women with an unmet need for family planning
were to use a contraceptive method, the CPR would
increase from 59% to 74%.
Education levels are closely linked to a woman’s fertility:
women with no formal education and women with a
primary education have between five and six children,
respectively, while women with at least some secondary
education have approximately four children or less [1]. In
addition, women and/or their partners in poor socioeconomic circumstances are less likely to use
contraception [7], specifically if the women are over 35
years old, less educated, own less household items,
and live in rural areas [8]. In Zimbabwe, 98% of women
and 99% of men know about at least one contraception
method [1]. Most of the women in rural areas depend on
mobile clinics and community based distribution for their
contraceptive supplies, while those in urban areas get

their supplies from clinics and pharmacies [9].
Government-sponsored facilities remain the main
providers of contraception with 73% of women who use
modern contraceptive methods obtaining them from the
public sector [1]. Table 1 overleaf provides with an
overview of family planning in Zimbabwe and four of its
provinces i.e. Harare, Masvingo, Matebeland South and
Matebeland North.
Zimbabwe has monitored the HIV epidemic to assess
HIV prevalence in pregnant women attending antenatal
care (ANC) services. The country has a generalised
heterosexually driven HIV epidemic with a prevalence of
14% [1]. 95% of women attended ANC at least once
during their most recent pregnancy [5] and an estimated
1,159,097 adults and children were living with HIV and
AIDS in 2011 [10]. While family planning programmes
have led to an increase in the percentage of women
using contraceptives and improvements have been in
the use of LARCs/PMs that are preferred by clients,
these offer no protection against HIV [11].
In Zimbabwe, women from all backgrounds are subject
to violence, where 27% of women reported that they
have experienced sexual violence at some point in their
lives and only 37% of women who have ever
experienced any physical or sexual violence have
sought help from any source [1]. Addressing gender
dynamics and the related issue of gender based
violence as part of integrated SRH services within
family planning [12], has been included in Ministry of
Health and Child Welfare (MoHCW) policies [13], as
experiencing violence increases a woman’s’ risk to HIV
and reduces contraceptive use [14].

2.1 Population Services Zimbabwe
PSZ, a member of Marie Stopes International, is one of
Zimbabwe’s largest specialised SRH organsations, PSZ
currently provides mobile outreach services in nine of
Zimbabwe’s ten provinces through eight teams visiting
over 500 sites at different times. The districts are
covered through a network of eight static clinics and
eight mobile outreach teams and take place in MoHCW
clinics, schools, private facilities, outdoors with
temporary structures etc. Expansion of these sites is
currently underway. PSZ aims to increase access to
family planning services for women, men and
adolescents in rural and hard-to-reach communities.
Mobile outreach services make use of an integrated
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Matebeleland
North

Masvingo

Harare

Indicator

Matebeleland
South

TABLE 1: Family Planning data for Harare, Masvingo, Matabeland South, Matabeland North and Zimbabwe

Zimbabwe

02

Total fertility rate per woman

4.1

3.1

4.7

4.2

4.1

Contraceptive prevalence rate (%)

59

59

54

46

51

(CPR) for modern methods

57

58.2

54.0

45.2

49.3

Female sterilisation

0.9

1.1

1.2

1.2

0.7

IUD

0.2

0.3

0

0.2

0.8

Male sterilisation

0

Pill

27.3

45.8

4.4

19.8

27.6

Injection

6.1

3.5

7.6

15.7

12.2

Male Condom

3.5

3.2

1.7

4.3

1.6

Female Condom

0.3

0.4

0.2

0

0

Traditional methods (withdrawal, periodic
abstinence)

0.8

1.2

0.2

1.0

1.4

Total unmet need for family planning

12.8

12.6

11.7

26.2

13.2

Unmet need for spacing births

5.5

7.1

9.0

13.7

6.2

Unmet need for limiting births

7.3

5.5

2.7

12.5

7.0

Maternal mortality ratio (MMR)

960 per
100,000
live births
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approach that combines community based information
education and communication (IEC) and service
provision. PSZ provides the full method mix of family
planning services (eg. condoms, pills, injectables,
implants, IUDs and PMs) through its outreach mobile
sites. PSZ has also embraced the global call for
repositioning family planning through integration of STI
and HIV services. Currently PSZ employs the
syndromic approach per national guidelines to screen
and treat for STIs. Mobile service delivery involves
having contraceptives provided by a team of trained
providers, either through periodic visits to a lower-level
facility or from a mobile unit itself in an area with limited
or no family planning services. Typically, a PSZ
outreach mobile clinic consists of a team of four and a
vehicle equipped to provide contraceptive services,
including LARCs/PMs, which often complement the
readily available short term methods and broaden
available methods and choices for women. Depending
on the location and methods provided, teams are
usually staffed by nurse aide, clinical officers, or
physicians, and a driver.
PSZ implements a quarterly internal quality technical
assistance (QTA) and an annual external QTA that
assesses infrastructure, supplies, procedure

correctness and inputs for an effective programme.
However, this does not include independent verification
of aspects of quality of counselling and information.
Additionally, the understanding of information on
relevant services, HIV integration, referrals, and
information on client and provider behaviour in the event
of a side effect experienced by the client, has not been
systematically documented. As part of their mobile
outreach quality assurance programme, MSI undertook
to evaluate the mobile outreach services in Zimbabwe,
which are delivered at primary health care (PHC)
facilities. Although this evaluation focused on services
provided by PSZ outreach teams, it aims to contribute to
the national knowledge base, especially in communities
where PSZ conducts and will conduct future mobile
outreach services. The evaluation will inform the
national family planning programme, as well as the
overall quality of services provided by PSZ nationally. In
2012, PSZ, added 268,919 couple years of protection
for clients accessing family planning services [15]. The
results from this evaluation are expected to guide PSZ
on how to further strengthen their mobile outreach
services and develop new strategies to enhance service
delivery standards. Table 2 documents the processes
PSZ undertakes for mobile outreach services.

TABLE 2: PSZ clinical standards for mobile outreach
Pre-procedure steps:
1.		 Comprehensive group family planning counselling: information is provided on all family planning methods, including
benefits and drawbacks, myths and misconceptions by a PSZ staff member.
2.		 Client registration.
3.		 One-to-one counselling: Clients are individually counselled using a client-centred approach, more detailed information is
provided regarding the method chosen by the client (including side effects) by a PSZ health care provider.
4.		 History taking and medical check-up/screening.
5.		 Voluntary and Informed consent obtained (given in writing by the client for permanent methods per MoHCW standards).
6.		 Medical tests as required, including urine and blood tests.
7.		 Anaesthesia provision (when indicated by method).
Post procedure follow-up care:
All clients at PSZ outreach sites complete registration and the recording of PSZ services are documented in the registers. All
clients are counselled post procedure on how to deal with side effects and instructions for after care. They are also given the
contact telephone number of the PSZ Helpline and PSZ Team Leader in case they were in need of contacting a PSZ provider.
Tubal ligation clients

Provided with pain relief, anti-inflammatory medication, tablets.

IUD clients

All IUD clients are counselled to return to the facility at six weeks post procedure and are
attended by MoHCW nurses. Three month and one-year follow ups occur when PSZ returns to
the outreach site.
Provided with pain relief medication.
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2.2 Study aims and objectives
This study was commissioned to complement PSZ’s
regular quality assurance procedures for outreach
services in Zimbabwe. The external evaluation,
conducted by Population Council, was designed to
focus on various components of quality including
adequate information and counselling on methods and
services, good clinical procedure with minimal
occurrence of adverse events and client satisfaction
with the services provided by outreach clinics.
Additionally, health seeking behaviour of clients was
evaluated in the event that side effects were
experienced. The findings of the study are intended to
be used by PSZ to improve quality of outreach services.
Quality was measured through data collection of direct
observation of client counselling and service provision,
client exit interviews on the day of service and at a 15
day follow-up visit.
Objective 1: To evaluate the quality of services (service
provision and counselling) provided to clients attending
mobile outreach services for a range of family planning
methods provided by the PSZ mobile health teams.

•		Sub-objectives
– Assess the quality and levels of satisfaction with
regard to counselling and information provided.
– Assess information provided to clients on what
steps to take if they experienced a side effect.
– Assess the level of integration of HIV services
into contraceptive or other SRH services.
Objective 2: Measure the occurrence of side effects
associated with LARCs/PMs up to 15 days postprocedure with an emphasis on understanding health
seeking behaviour for side effects.
•		Sub-objectives
– Measure the timing, frequency and type of side
effects occurring between 0 to 15 days.
– Assess women’s health-seeking behaviours
when experiencing a side effect.
– Determine access to follow-up care for women
with a side effect.

Methodology

3. Methodology
3.1 Study design, location and
participants
This evaluation involved recruiting a convenience
sample of 665 women receiving family planning
services from PSZ mobile outreach sites between
September and October 2013. Of all the provinces
PSZ is working in, the four provinces with highest
coverage, Harare, Masvingo, Matebeleland North and
Matebeleland South were selected on account of
having sites in which a high number of clients
accessed family planning services during the period
January to July 2013. Additionally, these provinces
provided a representation of urban, peri-urban and
rural areas.
Women were eligible to participate in the study if they
had received a family planning service, signed an
informed consent and indicated that they were willing
to return for the 15 day follow up visit.
Sampling
The sample size was guided by logistic considerations
and the need to ensure that the study evaluated the
quality of care provided by all eight PSZ mobile teams.
A sample size of 665 clients was achieved during the
data collection period, which represents an average of
83 women per mobile team.

Survey instrument, data collection and data
analysis
Each PSZ outreach team had an accompanying
research team of five people in total consisting of three
female data collectors, one nurse and one team leader
who carried out recruitment, conducted client exit
interviews and 15 day follow-up interviews. Clients
were recruited for the study prior to their procedure at
the outreach site, and following informed consent,
were observed whilst receiving counselling and family
planning service provision. During the client-provider
observation, the nurse explained her presence to the
clients and provided assurance that the privacy and
confidentiality of all study participants would be
maintained throughout the process.

During the procedure, the research nurse completed
the client-provider observation tool which included
questions on how the provider greeted and assessed
the client, family planning method selection and client
counselling and observation of specific processes.
Following the procedure, clients were interviewed
about their background characteristics; knowledge and
source of information about the outreach services;
previous use of contraception, satisfaction of the
service they had just received, experience of
immediate adverse event and reasons for opting to
receive the service from PSZ. Clients receiving tubal
ligation were given adequate time for recovery (a
minimum of 45 minutes) post-procedure prior to
conducting the exit interview. All clients were asked to
return to the clinic 15 days post-procedure and
received a follow-up card. The cost of travel for this
interview was covered by the study. At the Day 15
follow up interview, the interviewer collected
information on side effects, health care seeking
behaviour, resumption of normal activities and
satisfaction. If clients did not return to the site for a
follow up interview, attempts were made to contact
respondents by telephone only if the client had agreed
to be contacted during informed consent. At the Day
15 follow up visit, all clients that returned were asked
to consent again.
Data collection was conducted between 9th and 17th
September 2013. All data related to adverse events
(side effects or complications) on the day of the
procedure, at post-procedure or those that “still
existed” at the Day 15 follow up visit were collected
through client interviews. Table 3 provides a
description of adverse events that the clients were
asked to self-report on which was related to their
choice of family planning method.
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TABLE 3: Summary description of adverse events that clients were asked to report

Type of family
planning

Description of Symptoms

06

Implant

IUD

Tubal Ligation

Pain at insertion site

Pain at time of insertion

Bleeding at insertion site

Pain (related to cramping postinsertion)

Pain at time of
insertion

Menstrual cycle (change in
bleeding)
Scarring
Change in breast since
implants (eg. tenderness or
lumps)
Change in blood pressure
Infection (eg. Fever, pain,
redness or discharge at
insertion site)

Vaginal bleeding
Infection (eg. Fever, abdominal
pain, discharge)
Expulsion of IUD

Pain (related to
cramping postinsertion)
Vaginal bleeding
Infection (eg. Fever,
abdominal pain,
discharge)
Expulsion of IUD

Expulsion of implants

Data collection was conducted between 9th and 17th September 2013. All data related to adverse events (side
effects or complications) on the day of the procedure, at post-procedure or those that “still existed” at the 15 day
follow up visit were collected through client interviews. Table 3 provides a description of adverse events that the
clients were asked to self-report on which was related to their choice of family planning method.

TABLE 4: Categories of adverse events2

Type of adverse event

Description

Very mild

The client experiences low level of discomfort that does not require any medical
intervention

Mild

The client experiences some level of discomfort that only requires resting or minimum
level of medical intervention such as taking pain relief from a medical shop

Moderate

The client experiences more frequent level of discomfort that requires attention from
medical personnel, such as a doctor

Severe

The client experiences frequent level of discomfort that requires either further medical
check-up or hospitalisation

The study design, development of survey tools and data collection was managed by the Population Council. Data
was entered on data collection templates developed in Epi Info 7. Descriptive statistical methods were conducted
using the Statistical Package (STATA Version 12).
2

Adapted from a similar MSI outreach evaluation: Reiss K, Nantayi L, Odong J & Ngo TD. Providing long acting and permanent contraceptives through
outreach in rural Uganda. MSI, 2012
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4. Findings
4.1 Study recruitment
The sample was recruited from four provinces:
Harare, Masvingo, Matabeland South and Matabeland
North. The evaluation was conducted at 26 mobile
outreach sites in eight districts. The majority of

services were delivered in rural locations (77%) with
the remaining delivered in urban and peri-urban areas
(24% and 7% respectively). The facility level
distribution of implant, IUD and tubal ligation clients
recruited for the study is provided in Table 5.

TABLE 5: Respondents recruited by outreach mobile sites, district province and outreach teams. Distribution of
tubal ligation, IUD and implant clients recruited for the study by district
Mobile Outreach
Teams by Province

District

Mobile Team Sites

Number of
Respondents

1. Masvingo Outreach
Teams

Chiredzi

Chinzvinzvi

18

Chiredzi Poly

44

Ndali

29

Rupangwana

24

St Joseph

30

Feversham

27

Mashambanhaka

24

Nyanzou

8

Chipfunde

11

Manyika

16

Nhakiwa

28

Seke

Beatrice

20

Mutoko

Mushimbo

24

Ruwa

Ruwa

95

Umguza

Insiza

37

St James

10

Hope Fountain

25

Durban and Queens Mine

12

Kensington

29

Lupane

St Lukes

46

Umzingwane

Mzingwani

12

Sibomvu

40

Mawabeni

23

Mbizingwe

10

Habane

23

2. Harare Outreach
teams

3. Nkulumane Outreach
teams

4. Bulawayo Outreach
Teams

TOTAL

UMP

665
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4.2 Socio demographic characteristics

During the study period 702 clients were recruited to
participate in the study and out of these women, 665
were eligible to participate in the study. Those who
were not eligible could not be provided with
contraception due to medical reasons identified during
the consultation or had decided not to receive a family
planning method. Table 6 shows the distribution of the
sample for the clients recruited in each of the outreach
facilities. In total, 1% (n=7) of clients received a tubal
ligation, 7% (n= 48) of clients accepted IUDs and 92%
(n=610) of clients opted for implants. At the 15 day
follow up visit, 91% (n=555) of the required sample
size returned to the facility. While all of the tubal
ligation and IUD clients returned, 91% of implant
clients returned. 55 clients were loss to follow up (see
Figure 1).

The median age of clients was 26 years. Eight clients
were aged between 14 and 16 years old which are
included in the 15-19 year old group in the table below.
Almost three quarters (74%) of women were married
and almost all had more than one child (99%) (see
Table 7). The number of living children clients had was
fairly evenly distributed. The majority of clients had two
children (31%), while the remaining were evenly split
between those having one child, three children or four
or more children.

FIGURE 1: Study cohort profile

702 women registered for outreach services
Not eligible: 37

665 eligible clients to participate

Day 1

Day 15

7 tubal
ligation

610
Implants

48
IUD

100%
tubal ligation

91%
Implants

100%
IUD

Loss to follow
up: 55
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TABLE 6: Client socio-demographic characteristics
Socio-demographic characteristics
Age of women

(years)

(N=665) % (n)

[mean]

26 years

Under 20 (15-19)

12% (n=77)

20-24

31% (n=206)

25-29

24% (n=157)

30- 34

17% (n=110)

35+

17% (n=114)

Number of living children [mean]

3

0

0% (0)

1

22% (n=145)

2

31% (n=207)

3

23%(n=153)

4 or more

23% (n=145)

Education
Primary

39% (n=252)

Secondary

59% (n=384)

Graduate

1% (n=4)

Technical education

1% (n=9)

Professional education

1% (n=4)

Other

0%(n=1)

Occupation
Housewife

49% (n=324)

Petty business

8% (n=55)

Business including retail shop

1% (n=5)

Farmer

14% (n=94)

Agricultural labourer

7% (n=48)

Teacher

1% (n=4)

Factory / Production worker

0% (n=2)

Managerial / Professional

4% (n=23)

Office attendant

0% (n=2)

Student

1% (n=5)

Other

16% (n=103)

Average monthly household income

USD 177. 88

% of clients living under $1.25/day

6% (n=33)

% of clients living under $2.50/day

7% (n=36)

Client risk Profile
Disclosing family planning to partner

39% (n= 260)

Partner supportive of receiving family planning service

39% (n= 260)

Clients reported ever receiving an HIV test

95% (n=632)

HIV test in last 12 months

12% (n= 78)

last HIV test > 18 months ago

58% (n=383)

Self-reported sexual behaviour
One partner
Two partners in last 12 months
More than two partners in last 12 months
Unprotected sex in last 3 months

81% (n=481)
9% (n=49)
1% (n=5)
24% (n= 406)

“ever” used condom
“always” used condom

49% (n=272)
29% (n=79)
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4.3 Previous contraceptive use
To measure the degree to which outreach services
expand access and choice, particularly for LARCs/
PMs, clients were asked about prior contraceptive use.
All of the women in the study reported having used a
contraceptive method at some point prior to receiving
the PSZ service. The majority of clients reported use
of short-acting methods including the pill (n=328),
injectable (n=94) and male condoms (n=65). A
minority of clients reported that they were using a
long-acting method including IUD (n=5) and implant
(n=54). Clients were also asked whether they had
become pregnant whilst using a method of
contraception in the past. 62% of women reported that
they were using some form of contraception when they
became pregnant. The contraceptive pill was cited
most frequently as the failed method. Most of these
women (85%) reported switching to a LARC/PM after
the unplanned pregnancy.

4.4 Quality of care
Quality of counselling and information
To evaluate quality of care, the provider-client
interaction was observed to assess data collection on
whether a client-focused approach was used, the

quality of counselling and information, screening and
eligibility and post-procedure counselling. The client
provider observation tool was used by the research
nurses during observation. Observation was
conducted with all clients irrespective of the family
planning method chosen and the interaction between
the service provider and client during the procedure.
Confidentiality and privacy during the procedure was
also noted.
The client-focused approach specifically assessed
whether the provider: used the client’s name during the
consultation; used a kind and inviting voice; listened to
the client; encouraged the client to ask questions and
assisted the client in making a decision when choosing
an family planning method. Assisting clients in
decision-making involves providers giving nonjudgmental and non-directive support to ensure clients
make an informed choice and feel comfortable with
their SRH decisions. Client-provider observation data
indicates a generally high level of client-focused
approach in which 95% of interactions included using a
kind and inviting voice and listening to the client, and
83% encouraging clients to ask questions (see Figure
2).
Client-provider observations were supported with
findings from the client exit interviews which included

FIGURE 2: Elements of the client focused approach

Use client’s name

69%

Kind & inviting voice

95%

Listen to the client

95%

83%

Encourage client to ask questions

53%

Assist client in decision making

0%
Data Source: Client Provider Observation
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questions on client-centered approaches. Figure 3
shows the client reported data such as greetings and
mannerisms the provider displayed.
Quality of counselling and information provided by
providers was also found to be high. For all the clients
(100%), it was observed that they were provided with
information on the risks and benefits of the chosen
method of contraception as well as the risks and
benefits of using male or female condoms as a single
or dual method of protection against HIV. 94% of
interactions included provision of accurate information.
From the client exit interviews, 93% of clients reported
that they were provided with adequate information on
the different types of contraception available through
the PSZ mobile outreach services, 92% felt they were

aware of the risks and benefits of the different
contraception methods, side effects for each of the
contraceptive methods provided by PSZ and what to
do should they experience a side effect (95%). This
data was collected during the client exit interview after
the client had received both group and individual
counselling as well as the family planning method of
their choice.

Client history
Most providers captured the required elements of the
clients’ medical history during the visit. It was observed
that 94% of clients were asked about their obstetrics
history followed by hypertension (83%). Fewer than
half of clients (43%) were asked if they experienced
migraines or headaches by the provider. Only 36% of

FIGURE 3: Quality of care for family planning services

Friendly / respectful manner

97%

Used kind & inviting voice

97%

Provider listened

97%

Provider used client record

97%

Seen in a private area

99%

Received counselling base on family
planning choice

93%

94%

Provided with accurate information

87%

Provided with date of return visit

0%
Data Source: Client exit interview

20%

40%

60%

80%

100%
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clients were asked whether or not they smoked. Figure
4 and Table 8 provide details on specific screening
topics and history taking from client provider
observations.

Client satisfaction
At enrolment all clients (100%) stated that they were
happy and satisfied with the family planning service,
however only 21% of clients indicated that they would
“recommend the service” to a stranger, 57% to a family
member and 68% to a friend.
Client satisfaction was also recorded at the 15 day
follow up visit among the clients that returned. When
asked whether they would “recommend the family
planning method” to other women all tubal ligation

clients (n=7), 88% (n=38) of IUD clients and 89% (n=
471) of implant clients reported that they would
recommend their family planning method to other
women. However, one tubal ligation client, 6% (n=3) of
IUD clients and 1% (n=8) of implant clients said they
had some regret in having chosen their particular
family planning method. These clients were asked no
additional questions related to regret.
Overall satisfaction with the outreach service was the
same for groups of women accessing tubal ligation,
IUD and implant services, with 95% of clients
indicating that the quality of service they received was
either as expected or better than expected.
Two percent (n=6) of IUD clients were dissatisfied with
the service due to the attitude of the provider. These
clients (n=6) also indicated additional reasons for

FIGURE 4: Client history

78%

Breast feeding information

94%

Obstetrics history

53%

Antibiotics use

Current / past episodes of breast

74%

Episodes of migraines / headaches

43%

Heart diseases

48%

Diabetes

66%

Hypertension

83%

0%
Data Source: Client Provider
Observation
exit interview
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TABLE 7: Provider observation on quality of care

Asked about Medical History

Percentage of clients asked (%) (N= 665)
Smoking

36%

Diabetes

66%

Hypertension

83%

Heart disease

48%

Headache (migraine)

43%

Breast cancer (past and current)

74%

On antibiotics

53%

Obstetrics history

94%

Breastfeeding

78%

Asked about reproductive history

Percentage of clients asked (%) (N= 665)

Number of children alive

93%

Desired number of children

51%

Age of youngest child

72%

Timing of next birth

49%

Date of last menses

90%

Intercourse since last menses

43%

Signs and symptoms of pregnancy (tender breasts or nausea)

25%

Previous use of family planning

89%

Asked about STI and HIV risk

Percentage of clients asked (%) (N= 665)

Unprotected sex (vaginal, anal, oral)

24%

More than one concurrent partner

3%

Partner has more than one concurrent partner

2%

Injects Drugs

2%

Safer sex counselling carried out by provider
HIV Counselling

Percentage of clients asked (%) (N= 665)
61%

Individual situation taken into account during safer sex counselling

41%

All relevant options for safer sex discussed

38%

Abstinence

18%

Offered an HIV test

45%

Mutual monogamy

16%

Condom use

84%

Data Source: Client Provider Observation
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FIGURE 5: Recommending PSZ family planning services

Family planning service
met your needs

100%

Will use this service site again

100%

Recommend PSZ family planning
service to a friend

68%

Recommend PSZ family planning
service to a family member

57%

Recommend PSZ family planning
service to a stranger

21%

0%

20%

40%

60%

80%

100%

Data Source: Client Exit Interview

being unsatisfied with the service including the lack of
transport to the site (n=4), no provision of blankets
during the procedure (n=3) and insufficient financial
compensation for travel to and from the site of service
provision (n=3).3

Level of integration of HIV services into
contraceptive or SRH services
Each client was observed on whether they received

HIV and AIDS counselling, counselling on dual
protection, obstetrics history and breast cancer,
pregnancy testing, gender-based violence and STI
services (information, testing and treatment). 100% of
clients were provided counselling on dual protection,
with 61% receiving HIV and AIDS test counselling.
Table 8 provides with an indication of SRH related
services that were observed being provided to clients.

TABLE 8: SRH services that were offered to clients seeking family planning services at the PSZ outreach sites
SRH Services (N=655)

Responses % (n)

HIV and AIDS test counselling

61% (n= 399)

Counselling on dual protection

100% (n= 655)

Breast Cancer & other gynecological issues

62% (n= 406)

Pregnancy testing

27% (n= 176)

Gender-based violence

12% (n= 78)

STI services (information, testing and treatment)

58% (n=379)

Data Source: Client Provider Observation

3

It is PSZ practice to provide a reasonable amount of reimbursement for clients who accept permanent methods to support their transport home.
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4.5 Adverse events
Information on adverse events (including side effects
and complications) was collected on the Day 15 follow
up visit using the client follow up interview tool (see
Appendix). Interviewers asked about the existence and
severity of symptoms from the day of the procedure up
to and including Day 15 follow up. 91% (n=555) of
clients returned on Day 15 and completed the follow up
questionnaire.
Clients were asked to indicate the symptoms that they
experienced on day of the procedure; post procedure
(between the day of the procedure and the 15 day
follow up visit) and whether the symptoms were still
present at the 15 day follow up visit. It should be noted,
that client reports were not verified by clinical or
client-provider observation in relation to the medical
intervention required. For this study, based on the
clients’ self-reported symptoms and level of
intervention, adverse events were categorised as “very
mild”, “mild”, “moderate” or” severe” per Table 5 (see
page 15).

paracetamol. 1% (n=6) self-reported taking pain relief
medication for symptoms, which was categorised as
“mild” side effects and 14% (n=73) reported slight pain
(categorised as “very mild”) which they had
experienced only during the insertion of the Implant.
All tubal ligation clients experienced some amount of
pain on the day of the procedure. 71% of tubal ligation
clients experienced pain that was either “very mild” or
“mild” at the time of the procedure. 14% experienced
moderate pain and no clients experienced “severe”
pain.
IUD clients reported that some of them (2%, n=7)
experienced “severe” pain on the day of the procedure.
Bleeding that was categorised as “very mild” was
reported for 94% of implant acceptors and 27% of IUD
acceptors (including a combination of bleeding at
insertion site and vaginal bleeding). Of the IUD clients
that reported bleeding, 1% (n=3) reported that they
experienced bleeding which lasted up to three days
from the day of the procedure.

Adverse events on Day 15 post procedure
Occurrence and frequency of side effects
65% (n=386) of all clients reported experiencing
symptoms at some point between the day of the
procedure and Day 15. Most clients reported
experiencing side effects on the day of the procedure
and indicated they were expected. 32% (n=180) of
clients indicated that they experienced a side effect up
to Day 15. Among implant acceptors, 32% experienced
some side effect on the day of the procedure and 21%
stated they experienced side effects between the day
of the procedure and the 15 day visit. 3% (n=16) of
these clients stated they still experienced the side
effect, however, only one client had to have their family
planning method removed. Among tubal ligation
acceptors (n=7), one reported still experiencing the
side effect at Day 15.

Adverse events on day of procedure
The summary of adverse events reported on the day of
the procedure is detailed in Table 9. Amongst the
implant clients 32% (n=168) reported experiencing
pain. 17% (n=89) were categorised as experiencing
“moderate” pain, requiring something stronger than

All tubal ligation clients returned for the 15 day follow
up visit. 57% (n= 4) and 29% (n=2) of clients reported
experiencing pain and bleeding respectively. One
client was recorded as experiencing mild haematoma
or bruising but no treatment was required. One other
client experienced bruising that required wound
revision and the release of build-up of blood.
At Day 15, as compared to tubal ligation acceptors, a
higher proportion of IUD clients reported side effects,
such as pain and bleeding. 73% (n=35) of IUD clients
reported experiencing some type of pain. 62% of
these clients were categorised as reporting either
“very mild” or “mild” pain. 10% of these clients were
categorised as experiencing “moderate” pain. Three
clients reported still “experiencing severe cramping
pains”, and three clients reported “abdominal pain
during intercourse since IUD insertion”. Two clients
reported experiencing “slight temperature and fever,
abdominal pain, unusual discharge developed within
the 15 days following IUD insertion”, one client
reported experiencing a “constant high temperature
(required antibiotics and improved within seven days)”
and another client reported experiencing “no
improvement after seven days of antibiotic treatment”.

15

16

Findings

TABLE 9: Types of adverse events experienced on the day of procedure
Implants
(Jadelle)
(N=532)

IUD
(N=48)

Tubal ligation
(N=7)

Very Mild

14%

2%

29%

Mild

1%

1%

43%

Moderate

17%

-

14%

1%

-

168

17

7

Very Mild

94%

27%

14%

Mild

6%

2%

0

Moderate

0

0

0

Severe

0

1%

0

206

24

1

Implants
(n=532)

IUD
(N=48)

TL (n=7)

Very Mild

15% (n=79)

27% (n=13)

29% (n=2)

Mild

5% (n=25)

35% (n=17)

14% (n=1)

Moderate

1% (n=4)

10% (n=5)

14% (n=1)

Severe

0% (n=1)

-

-

109

35

4

Very Mild

2% (n=8)

35% (n=17)

14% (n=1)

Mild

-

8% (n=4)

-

Moderate

-

2% (n=1)

-

Severe

-

-

15% (n=1)

8
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2

Signs and symptoms reported experienced
on day of procedure
Pain

Severe
Total “Pain” side effect
Bleeding

Total “bleeding” side effect
Data source: 15 day follow up interview

TABLE 10: Types of adverse events experienced at 15 days post procedure

Pain

Total “pain” side effects reported
Bleeding at insertion
site for “Implants
and Tubal Ligation”&
“Vaginal bleeding”
for IUD

Total “bleeding” side effects reported
Data source: 15 day follow up interview
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TABLE 11: Implant clients self-report on menstrual bleeding and breast tenderness
Menstrual bleeding
Lighter, fewer days, irregular and infrequent

8% (n=45)

Prolonged bleeding that lasts longer than 8 days

3% (n=17)

Heavier bleeding that is 2 times as usual

1% (n=6)

Heavy or prolonged bleeding continuing

2% (n=12)

Change in breast since Implants
New lump in breast since Implants inserted
Breast tenderness & soreness

0.17% (n=1)
0.3% (2)

Data source: 15 day follow up interview

Of the 532 implant clients who participated in the
follow-up interview on Day 15, 64% (338) reported
some level of pain at some point in time. There were
no reports of bleeding at Day 15. 15% (n=79) of clients
reported pain that continued for more than one day
post-procedure. This side effect was categorised as a
“very mild” side effect.
Information was collected from implant acceptors
related to menstrual bleeding and breast tenderness
(see Table 12). 3% (n=17) of clients experienced
prolonged bleeding lasting longer than eight days.

4.6 Follow up care and health seeking
behaviour by Day 15
All clients who attended the follow up visit and
reported experiencing an adverse event were asked
whether they sought care irrespective of the level of
severity. 96% of clients reported that no care or
additional treatment was required for their side effect.
Figure 6 shows the reasons clients cited for not
seeking care. Most clients indicated that they did not
get time off from their household chores to seek care.
Additionally, lack of concern from their partners or
family members and thinking that the side effect
symptoms will subside over time, were cited as well.
Two percent (n=8) of clients reported seeking care at a
health facility however only 63% (n=5) reported that

they were satisfied with the help that they had received
and the remainder of the clients who were not
satisfied, cited that they still experienced the side
effect at the Day 15 follow up visit.
Another 2% (n=8) reported that they had contacted
PSZ to discuss care and treatment. All these clients
reported that they were advised to return to the health
care facility and see a facility provider, should their
symptoms continue, however only 50% (n=4) of these
clients returned to the facility and were seen by a
facility provider prior to the Day 15 follow up. These
clients reported that the facility provider dispensed
“pain medication” and that they received counselling
and were asked to return at the Day 15 follow up and
report to the PSZ provider any side effects that they
were still experiencing.
The 50% of clients who did not return to the facility
indicated that the facility was too far and that they
would wait for the Day 15 follow up visit to return to the
clinic.
A review of the side effects of the 2% of clients that
contacted PSZ indicated that the “pain” & “bleeding
around the insertion site” was reported, however these
symptoms had subsided and these symptoms were no
longer experienced at the 15 day follow up visit.
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FIGURE 6: Reasons for clients not seeking health care when experiencing adverse event

78%
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99%

Did not get time off
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2%
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Data Source: 15 Day Follow-Up tool

Resumption of normal activities and work
7% (n=3) of the IUD clients, and 2% (n=8) of implant
clients reported that they were still unable to work as
normal on Day 15 post-procedure. Of the clients who
reported being unable to work, two IUD clients and
four of the implant clients attributed this to pain, one of
the IUD clients and three of the implant clients said it
was due to insertion site bleeding, and 7% (n=3) of
IUD clients and 0.4% (n=2) of implant clients reported
“back ache” as the reason for non-resumption of
normal activities and work.

4.7 Myths and misconceptions
All clients were asked whether they agreed with
common misconceptions of family planning at the
client exit interview. It was interesting to note that a
large percentage of clients (52%) thought that
“condoms often break during sex”. Some commonly
reported beliefs included: women who have never had
a baby cannot use an IUD or DMPA and IUDs cause
discomfort to the partner during sex. Some clients felt
that hormonal contraceptives could cause cancer and
as many as 29% of clients said pills can make a
woman sterile. Detailed findings on myths and
misconceptions are shown in Table 12.
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TABLE 12: Myths and misconceptions as reported by the client
Contraception
IUD

Hormonal (Injectable)

Hormonal (“Pill”)

Misconception

Percentage
(N=665)

An IUD can travel from the woman’s uterus to other parts of
her body, such as her heart or brain

13% (n=85)

An IUD can prevent a woman from having babies after it is
removed

15% (n=96)

An IUD can prevent a woman from having babies after it is
removed

20% (n= 27)

A woman should have a “rest period” after using an IUD for
several years

9% (n= 55)

An IUD will cause discomfort to the woman’s partner during
sex

26% (n= 167)

Women without children cannot use depot
medroxyprogesterone (DMPA)

23% (n= 146 )

DMPA causes cancer

19% (n=121)

DMPA causes abortion

12% (n= 76)

“Pills” cause cancer

16% (n= 84)

A woman should take a break from “pills” after some time

8% (n=45)

“Pills” will cause deformed babies

18% (n=108)

Pills” can make a woman sterile

29% (n= 168)

A woman should not take “pills” if she has not had a baby

24% (n=154)

“Pills” can make a woman weak

16% (n=85)

Data Source: Client Exit questionnaire
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5. Discussion and
recommendations
5.1 Discussion
PSZ mobile outreach services are an ideal platform to
provide clients with integrated services especially
around HIV and STIs. Clients are offered a full method
mix of contraception during PSZ visits, but the uptake
of IUD, tubal ligation and Implants tends to be high as
other short acting methods of contraception are
routinely available to women through the MOHCC
service delivery. The study has shown that levels of
satisfaction with PSZ services are high and there are
low levels of severe adverse events. The analysis
indicated that clients received accurate family planning
information and that they were happy with the quality
and quantity of information pertaining to their choice of
family planning including how to manage common side
effects.

Quality of care
The analysis revealed that in the majority of cases
(83%), providers encouraged clients to ask questions
to establish their understanding of family planning. This
interaction and discourse may have contributed to
clients indicating that they would return to the site for
family planning services as a strong rapport was often
built. All providers were observed taking the client’s
medical history and, the data revealed that some
information – such as obstetric information – was taken
for a large percentage of clients. Although all clients
(100%) stated that they were happy and satisfied with
the family planning service, not all clients indicated that
they would refer a friend or a family member to the
family planning site. 21% of clients indicated that they
would refer the service to a stranger. It is likely that
clients indicated low referral to family, friends and
strangers due to family planning being considered a
personal issue that should not be discussed with
others. With regard to integration of other SRH
services, 61% of clients were asked about risk factors
for HIV, offered or referred for an HIV test. Given the
high prevalence of HIV in this sexually active client
population accessing contraceptive services, there is
room for strengthening this aspect of service provision.

Incidence of side effects
The analysis revealed that clients were informed and
knowledgeable about potential side effects and what
action to take should they experience a side effect.

Most clients (94%) received information on what to do
if they experienced a side effect, and the information
was relevant to their contraceptive method. Client’s
health-seeking behaviour was documented by what
they did before arriving at the clinic for their Day 15
visit. The data showed that clients were able to seek
assistance when they experienced a side effect as
they knew how to access the facility and 2% of clients
called the PSZ helpline. 65% (n=386) of clients
reported experiencing symptoms at some point
between the day of the procedure and Day 15. Most
clients reported experiencing side effects on the day of
the procedure and indicated they were expected. 32%
(n=180) of clients indicated that they experienced a
side effect up to Day 15.

Study limitations
This study provided an overall indication of the quality
of family planning services (objective 1) and the timing,
frequency and type of side effect/s (objective 2)
experienced. Certain limitations were encountered.
Clients who returned to the facility prior to the 15-day
follow-up visit were unable to provide complete
information about their consultation/visit with the
facility providers. This included the type of treatment
received and the purpose of the drugs dispensed for
the side effect that they were experiencing. The study
relied on self-reporting by the client. The study did not
track the follow-up care of the 1% of clients who had
their family planning method removed due to side
effects experienced. The study also did not explore
why, despite being satisfied with the service and willing
to use it again, only 68% of clients indicated that they
would refer the family planning service to a friend, 57%
would tell a family member about the family planning
services and 21% would tell a stranger about the
service.
The follow up period of 15 days was short, and
therefore the study does not provide a good reflection
of longer term side effects, such as changes in
menstrual bleeding which may emerge over time, or of
discontinuation behaviours over a longer term.
Due to the small sample size (related to the duration
and available resources for the study) it was not
possible to further analyse the characteristics of the
clients who experienced side effects from IUDs and
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ultimately discontinued the method. Due to the follow
up processes in the study design, it was difficult to
further determine the exact cause of the (small)
number of side effects.
While clients were asked about receiving their
preferred family planning method, their reasons for
seeking family planning services and rationale for the
selected method were not explored in this study.
Partner, spouse or family member involvement was not
addressed in this study as it is known that women are
not only influenced or informed by their choice of
method by providers but by close family members as
well.
As with other prospective studies measuring post
procedure outcomes, without strict medical verification
and control, it is difficult to differentiate side effects as
a result of the procedure from symptoms relating to the
clients’ conditions or living environment that may
exacerbate the client’s experience of side effects.

5.2 Conclusion
The study aimed to evaluate the quality of care
provided by PSZ mobile outreach model in Zimbabwe.
The findings reveal that PSZ provides a critical health
service to women, especially those between the age of
15 years and 29 years who live in rural areas. PSZ
mobile teams expand access and choice of family
planning methods to women who otherwise would not
receive these services. Overall, clients indicated that
they were satisfied with the quality of services they
received from PSZ. Clients were well informed on how
to manage side effects and their health-seeking
behaviour attested to this. In addition, health-seeking
behaviour such as seeking care at the facility, calling
the PSZ helpline and returning at the 15 day follow-up
visit (which was facilitated by the study and does not
happen during normal operations) is an indication that
women are aware of how to seek care and what to do
in the event of a side effect. Determining access to
care was also assessed and the data revealed that the
women received the service they needed when they
arrived at the facility or the mobile site. At the Day 15
follow up, one woman experienced a severe side effect
(an implant user reporting pain) and no complications
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were reported amongst those clients interviewed.
These rates are similar to other published studies of
the experiences of mobile outreach clients [16, 17].
This study also highlighted areas of service that
require strengthening and opportunities to improve
integrated SRH service delivery such as testing and
re-testing for HIV, partner involvement and STI
treatment and care and the potential to provide more
information on other sexual and reproductive health
issues.

5.3 Recommendations
It is recommended that PSZ consider the following to
strengthen services:
•		 Clients are at significant risk of HIV and there is an
opportunity to integrate more information and HIV
related services into the routine family planning
consultation.
•		 A significant proportion of clients continue to have
misconceptions and incorrect information about
various contraceptive methods. PSZ health care
providers should continue to focus on correcting
myths and misconceptions routinely in group or
individual counselling as part of their family
planning community outreach activities.
•		 Although in some instances providers are using the
family planning consultation to integrate information
on other sexual and reproductive health issues,
there is room for strengthening this component and
reducing missed opportunities to provide
information.

As documented in the DLHS3, for 2007-2008 survey the SLI index for the state of Rajasthan was low 25.5%; medium 29.5%; and high 28.8%.
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